Navigation Links
Take Third Generation Oral Contraceptives Off the Shelves-consumer Group Insists

Public Citizen- an advocacy group for the protection of consumer health has come out strongly against the FDA//.

According to them the fact that third generation oral contraceptives have twice the risk of potentially fatal blood clots, a side effect of the synthetic hormone used in it, than second generation birth control pills, was known to the FDA, yet it has allowed the sale of these drugs for the last 12 years.

"While the use of any type of combined oral contraceptive holds an increased risk of venous thrombosis (blood clots), third-generation birth-control pills double that risk without preventing pregnancy any more effectively than older pills do” states Dr. Sidney Wolfe, director of Public Citizen's Health Research Group.

All contraceptive pills carry a very low risk of blood clots (due to venous thrombosis) that, even more rarely, can travel to the lungs and kill. It is a side effect of the pills' hormones, estrogen and progestin.

Second-generation birth-control pills contain norgestrel, levonorgestrel or norethindrone while third generation pills contain a synthetic type of progestin called desogestrel.

Third-generation birth-control pills were developed in the 1980s in an attempt to create an oral contraceptive that caused fewer side effects than earlier versions such as acne and unwanted hair.

In December 1995, three independent studies concluded that third-generation pills were about twice as likely as second-generation versions to cause blood clots. This was followed by other studies with similar results.

Accordingly users who may be subject to these potentially fatal blood clots are 30 in 100,000 as against 15 in 100,000 in those taking second-generation pills.

Yet says Vanessa Cullins, of Planned Parenthood, an organization which is opposing Public Citizens petition, ``Desogestrel pills should not be taken off the market; they are safe and very effective.

“ It is true that birth-control pills raise the incidence of blood clots over not using them, yet you have to put it into context. For women who aren't using any form of hormonal birth control and who aren't pregnant, the risk is four out of 100,000. For all birth-control pills, the risk is 10 to 30 in 100,000, while in pregnancy the risk of blood clots is 60 in 100,000.

``What we are talking about is a slight rate of increase in a very rare event. For some women desogestrel is a better choice than other drugs'', she concludes.

Yet, Public Citizen argues that since studies have shown third generation pills do not have any added advantage over second generation pills, why continue with a pill that has double the risk of blood clots?
AN
'"/>




Related medicine news :

1. Third artificial heart patient introduced
2. Third generation Small pox vaccine from Cell-culture
3. Surgery Offers Better Treatment For Third Degree Piles
4. One Third Of All Cancers Preventable!
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Kleins Third Way Has Tough Opposition
7. Ignorance about AIDS rampart in Third of College Students: Chinese survey
8. Jalgaon: Third Phase Of Culling Operations Begin
9. Pramod Mahajan Undergoes Third Surgery
10. Third Arm Removed Successfully
11. Erection Drug Was Not Useful to Two-Thirds of Its Users
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/16/2017)... , ... January 16, 2017 , ... ... attorney, science teacher, http://www.ageofautism.com/legal , Sharon Kleyne, America’s leading water educator, ... to her nationally syndicated radio program, The Sharon Kleyne Hour Power of Water, ...
(Date:1/16/2017)... PARK CITY, UT (PRWEB) , ... January 16, 2017 , ... ... expensive disease not only to treat, but to test for, as well. The money ... $88.7 billion every year.(1) Doctors in the U.S. screen patients for cancer more than ...
(Date:1/16/2017)... ... January 16, 2017 , ... NexTec Group has been selected as a ... honored for their accomplishments in the field of midmarket financial software. , Members of ... and innovation. Selection is not based on revenue and those firms chosen represent a ...
(Date:1/15/2017)... ... January 15, 2017 , ... Whole Health Supply, LLC is announcing the release of an updated ... avenues for purchase. , The 2017 edition has wide jaws that will accommodate nails ... boomers as well as diabetics. This handle is reinforced for extra strength when pressing down ...
(Date:1/15/2017)... ... January 15, 2017 , ... San ... in eight Bay Area counties for 2017. Almost 1,000 nominations were submitted and ... the award process. Results were announced the magazine’s January 2017 issue . ...
Breaking Medicine News(10 mins):
(Date:1/15/2017)... , January 16, 2017 Le ... innovants à base de collagène pour la régénération de tissus ... au poste de directeur général avec effet immédiat. ... Bill est un ... a occupé plusieurs postes de gestion générale et de direction ...
(Date:1/13/2017)... , Jan. 13, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... VP of Corporate Finance and Investment Banking at Eli Lilly ... effective immediately. Mr. Bott brings over 28 years of senior ... ... Martin Bott has established a significant leadership position in ...
(Date:1/13/2017)... York , January 13, 2017 ... prevalence of AIDS will collectively contribute to the demand for ... to reach a value of US$ 551.0 Mn by 2016 ... will remain the most lucrative markets for western blotting, whereas ... the market globally. ...
Breaking Medicine Technology: